Chief of General Surgery, Chief of Liver, Intestine and Pancreas Transplant, Hospital Universitario, Fundación Favaloro, Buenos Aires, Argentina.
Hum Immunol. 2024 May;85(3):110788. doi: 10.1016/j.humimm.2024.110788. Epub 2024 Mar 22.
The intestines have been considered the "forbidden organ" for years, and intestinal failure became the last organ failure recognized as such in the medical field. The impossibility of providing adequate nutritional support, turned these patients into recipients of just palliative comfort. In the 1960's, parenteral nutrition appeared as the most reasonable replacement therapy, but the initial success obtained with clinical kidney, heart, liver, lung and pancreas transplantation served as background to explore intestinal transplantation. The first clinical report of an isolated intestinal transplant was done by Richard Lillihei in 1967; in 1983, Thomas Starzl, performed the first multi visceral transplant, and in 1990, David Grant performed the first combined liver-intestinal transplant in an adult recipient in Canada. Since then, advances in immunosuppressive therapies and surgical innovations have allowed not only a continuous increase in indications, but also a worldwide application of all procedures, bringing clinical intestinal transplantation to reality. In this historical account, the most important contributions have been summarized, thus describing the steady progress, expansion and novelties developed over the last 56 years, since the first attempt. Clinical intestinal transplantation remains a complex and evolving field; ongoing research and technological advancements will continue shaping its future.
多年来,肠道一直被视为“禁忌器官”,而肠衰竭成为医学界最后一种被认定为衰竭的器官。由于无法提供足够的营养支持,这些患者只能接受姑息性治疗。20 世纪 60 年代,肠外营养作为最合理的替代疗法出现,但最初在临床肾、心、肝、肺和胰腺移植中取得的成功为探索肠移植提供了背景。Richard Lillihei 于 1967 年首次进行了孤立性肠移植的临床报告;1983 年,Thomas Starzl 进行了首例多脏器移植;1990 年,David Grant 在加拿大为一名成年患者进行了首例肝肠联合移植。此后,免疫抑制治疗和外科创新的进步不仅使适应证不断增加,而且使所有手术在全球范围内得到应用,使临床肠移植成为现实。在这个历史记载中,总结了最重要的贡献,从而描述了自首次尝试以来,过去 56 年来稳定的进展、扩张和创新。临床肠移植仍然是一个复杂和不断发展的领域;正在进行的研究和技术进步将继续塑造其未来。